Dudley Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$543K Hold
1,084
0.22% 86
2026
Q1
$533K Hold
1,084
0.23% 81
2025
Q4
$628K Hold
1,084
0.27% 78
2025
Q3
$526K Hold
1,084
0.24% 83
2025
Q2
$439K Hold
1,084
0.22% 84
2025
Q1
$539K Hold
1,084
0.28% 72
2024
Q4
$564K Hold
1,084
0.28% 69
2024
Q3
$670K Hold
1,084
0.35% 67
2024
Q2
$599K Hold
1,084
0.33% 67
2024
Q1
$626K Sell
1,084
-1
-0.1% -$561 0.37% 66
2023
Q4
$576K Hold
1,085
0.37% 64
2023
Q3
$549K Hold
1,085
0.39% 62
2023
Q2
$566K Sell
1,085
-128
-11% -$69.1K 0.38% 63
2023
Q1
$699K Hold
1,213
0.48% 57
2022
Q4
$668K Buy
+1,213
New +$643K 0.47% 61

Other funds holding TMO

Dudley Capital Management's TMO Position: Q2 2026 in Review

Dudley Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,084 shares worth $543K. The position accounts for 0.22% of the portfolio, ranked #86.

Dudley Capital Management first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $699K in Q1 2023. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Dudley Capital Management held 1,084 shares of Thermo Fisher Scientific worth $543K as of Q2 2026.
  • Dudley Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.22% of Dudley Capital Management's portfolio in Q2 2026, its #86 holding.
  • Dudley Capital Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Dudley Capital Management's Thermo Fisher Scientific position peaked at $699K in Q1 2023.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.